For more than 15 years, Surya Narayan Gainju has been one of the people working behind the scenes to help patients at Patan Hospital in Nepal receive the medicines they need.
As Chief Pharmacist at the hospital, Surya supports The Max Foundation across a wide range of responsibilities, from import permits and customs clearance to inventory management, medicine storage, documentation, and coordination with government authorities and hospital teams.
Nearly 1,500 patients at Patan Hospital receive treatment through Max Access Solutions each month. For those patients, receiving their medicine may be one part of a hospital visit. Behind that moment, however, is a long chain of work that has to happen consistently and accurately.
Our visit to Patan Hospital earlier this year offered a closer look at just how central Surya’s role is to the program. His work extends well beyond managing medicines, connecting hospital teams, regulatory processes, inventory, and the daily coordination needed to keep patient access running smoothly.
Surya works closely with physicians, hospital staff, government authorities, and The Max Foundation to support Max Access Solutions in Nepal. His responsibilities include securing import permits through the Ministry of Health, coordinating customs and regulatory processes, overseeing medicine receipt and storage, managing inventory, and maintaining patient and dispensing records.
Each of these steps matters. Delays in documentation, import processes, or medicine supply can ultimately affect patients who depend on continuous treatment.
Over the years, the program in Nepal has also grown. Today, we provide access to 14 innovative therapies for people living with cancer and rare diseases, adding further complexity to the work required to manage medicines responsibly and keep the program running. For Surya, much of that work happens away from public view.
Our local Max program coordinator, Sweta Agrawal, describes him as calm, clear about his responsibilities, and always ready to help. Once something is discussed with him, she says, the team rarely needs to follow up twice. He takes it forward and makes sure it gets done.
Working with the program for so many years has also given Surya a firsthand view of what sustained access to treatment can mean for patients and their families. He has seen people regain their health, return to work, support their families, and continue with their lives. Some patients who joined the program years ago remain on treatment today.
These outcomes depend on many people working together, from physicians and program teams to health authorities, supply chain partners, and hospital staff.
Pharmacists are a critical part of that network. Their role may not always be the most visible, but in programs like ours, their expertise helps medicines move through complex regulatory and hospital systems and, ultimately, reach the patients who need them.
On World Pharmacists Day, we recognize Surya and pharmacists around the world whose work extends far beyond dispensing medicine. For patients, much of that work may remain unseen. Its impact does not.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Introducing Dr. Aitbu Amankulova from Kyrgyzstan! She has worked as an oncologist-hematologist for more than 10 years and has been a Max partner physician since 2025. Learn more about her below. Describe a typical work week: My workdays are filled with patient consultations, follow-up care, medical documentation, and communication with colleagues. Every day is different….
We’re often reminded of why we put an effort in supporting people facing cancer – whether it comes through a patient story or through an organization’s investment in our work. This week, we humbly received another reminder: on Friday, May 22, the International Chronic Myeloid Leukemia (CML) Foundation awarded our CEO Pat Garcia-Gonzalez with the inaugural ERSAP (Emerging Region Support and Partnership) Prize. The iCMLf Directors and Scientific Advisors selected Pat because of her continued commitment, and The Max Foundation’s aim, to help people face cancer with dignity and hope.
In 2001, The Max Foundation partnered with the pharmaceutical corporation Novartis to develop an international treatment access program for people living with chronic myeloid leukemia (CML). Since then, we’ve helped thousands of patients in low- and middle-income countries access life-extending diagnostics, medication, and support services. A lot has changed over the years, but our focus….
